Journals / Haseki Tıp Bülteni / 2013 / Cilt: 51 - Sayı: 2

Helicobacter pylori in children with familial Mediterranean Fever

Ailevi Akdeniz ateşli çocuklarda Helicobacter pylori

Pages
41–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: H.pylori seems not to be crucial for the sake of frequency of attacks and APRs other than ESR and CRP However, since H. pylori is frequently encountered in the population and due to its trigger effect on inflammation, the determination and eradication of H. pylori needs to be further evaluated in larger populations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To investigate if Helicobacter pylori (H.pylori) infection is associated with acute phase reactants (APRs) and attacks in children with familial Mediterranean fever (FMF).
📊
Key Findings & Data:Methods: The study group consisted of 30 patients with FMF (mean age: 9.2±4.7 years (range: 4-15) diagnosed based on the Tel Hashomer criteria and molecular analysis.
💡
Conclusion & Impact:Conclusion: H.pylori seems not to be crucial for the sake of frequency of attacks and APRs other than ESR and CRP However, since H. pylori is frequently encountered in the population and due to its trigger effect on inflammation, the determination and eradication of H. pylori needs to be further evaluated in larger populations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To investigate if Helicobacter pylori (H.pylori) infection is associated with acute phase reactants (APRs) and attacks in children with familial Mediterranean fever (FMF). Methods: The study group consisted of 30 patients with FMF (mean age: 9.2±4.7 years (range: 4-15) diagnosed based on the Tel Hashomer criteria and molecular analysis. All participants were receiving colchicine and were attack-free at the time of study. The analyses included white blood cell (WBC), erytrocyte sedimentation rate (ESR), acute phase reactants (APRs) (c-reactive protein (CRP), fibrinogen, haptoglobin, ceruloplasmine), and Carbon-14 breath test for H.pylori. Results: H. pylori breath test was positive in 14 patients (46%; Group I) and negative in 16 patients (54%; Group II). Despite colchicine treatment, the rate of patients experiencing at least one FMF attack per year was 57.14% in Group I (ratio: 8/14) and 56.25% in Group II (ratio: 9/16) (p>0.05), thus, showing no significant relationship between attack frequency and H. pylori positivity in patients with FMF Among the other laboratory analyses, only ESR (10.25 mm/h in Group I vs. 6.42 mm/h in Group II) and CRP (5.4 mg/dl in Group I vs. 2.8 mg/dl in Group II) showed a statistically significant difference between the groups (p<0.05). Conclusion: H.pylori seems not to be crucial for the sake of frequency of attacks and APRs other than ESR and CRP However, since H. pylori is frequently encountered in the population and due to its trigger effect on inflammation, the determination and eradication of H. pylori needs to be further evaluated in larger populations.

Özet

Amaç: Bu çalışmada Ailevi Akdeniz Ateşli (AAA) çocuk hastalarda Helicobacter pylori (H. pylori) pozitifliği, bunun akut faz reaktanları (AFR) ve atak sıklığı ile ilişkisi araştırılmıştır. Yöntem: Çalışmaya yaş ortalamaları 9.2±4.7 yıl (4-15 yaş) arasında değişen 30 AAA’lı hasta alındı. Hastaların tanıları Tel Hashomer kriterleri ve gen mutasyonları eşliğinde konulmuştu. Bütün hastalar kolşisin tedavisi almaktaydı. Ataksız dönemde olguların beyaz küre (BK) sayısı, eritrosit sedimentasyon hızı (ESH), akut faz reaktanları (C-reaktif protein [CRP]), fibrinojen, haptoglobulin, seruloplazmin) çalışıldı. Tüm olgulara C-14 üre nefes testi yapılarak H. pylori pozitifliği araştırıldı. Bulgular: On dört hastada (%46) C-14 üre nefes testi ile H. pylori pozitif saptandı (Grup I), 16 hastada ise (%54) negatif bulundu (Grup II). Ayrıca Grup I’deki 14 hastanın, 8’inde (%57.14), Grup II’deki 16 hastanın 9’unda (%56.25) atak sıklığı, düzenli kolşisin tedavisine karşın yılda 1 veya daha sık saptandı. Atak sıklığı ile H. pylori pozitifliği arasında bir ilişki bulunmadı. ESH (10,25 mm/ s’a karşın 6.42 mm/s) ve CRP düzeyleri (5.4 mg/dl’e karşın 2.8 mg/dl) olarak Grup I’de yüksek bulunurken (p<0.05), diğer akut faz reaktanları arasında fark görülmedi. Sonuç: H. pylori pozitif ve negatif hastalar arasında atak sıklığı ve akut faz reaktanları açısından (ESR ve CRP hariç) anlamlı fark bulunmadı. Bununla birlikte, H. pylori’nin sık görülen bir etken olması ve inflamasyonu uyarıcı etkisi yönünden AAA’lı hastalarda tanısının ve eradikasyonunun önemli olabileceği, daha geniş hasta popülasyonlarının değerlendirilmesi gerektiği kanısına varıldı.

🔖

Cite This Article

KALMAN, S., DURANOĞLU, L., SAKALLIOĞLU, O., EMER, Ö., GÖK, F. (2013). Helicobacter pylori in children with familial Mediterranean Fever. Haseki Tıp Bülteni, Cilt: 51 - Sayı: 2, 41–44. https://ajindex.com/articles/267949

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Bakkaloglu A. Familial Mediterranean fever. Pediatr Nephrol 2003;18:853-9
  2. Zemer D, Revach M, Pras M, et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Eng J Med 1974;291:932-4
  3. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000;22:283-97
  4. Mourad-Baars P Hussey S, Jones NL. Helicobacter pylori infection and childhood. Helicobacter 2010;15: Suppl 1:53-9
  5. Sherman PM, Lin FY. Extradigestive manifestation of Helicobacter pylori infection in children and adolescents. Can J Gastroenterol 2005;19:421-4
  6. Gasbarrini A, Franceschi F Gasbarrini G, Pola P Extraintestinal pathology associated with Helicobacter infection. Eur J Gastroenterol Hepatol 1997;9:231-3
  7. Ozel AM, Demirturk L, Aydogdu A, et al. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever. Int J Clin Pract 2008;628:754-61
  8. Pras M, Sohar E. Familial Mediterranean fever. In:Klippel JH, Dieppe PA, eds. Rheumatology, St.Louis.Mosby; 1994.p.3-4
  9. Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol 2011;7:105-12
  10. Tunca M, Akar S, Onen F et al. Familial Mediterranean fever (MFF) in Turkey: results of a natonwide multicenter study. Medicine (Baltimore) 2005;84:1-11
  11. Ozen S, Bilginer Y, Aktay Ayaz N, Calguneri M. Anti-interleukin 1 treatment for patients with familial mediteranean fever resistant to colchicine. J Rheumatol 2011;38:516-8
  12. Kalman S, Sakallıoğlu O, Doğru İ, Gül D, Gök F Ailesel Akdeniz ateşli çocuklarda genotipin plazma ve idrar adrenomedullin düzeylerine etkisi. Turkiye Klinikleri J Int Med Sci 2012;32:453-8
  13. Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis 2009;68:246-8
  14. Pacifico L, Anania C, Osborn JF Ferraro F Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol 2010;16:5184-94
  15. Correa P Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007;133:659-72
  16. Coşkun S, Kasırga E, Yilmaz O, et al. Is Helicobacter pylori related to endothelial dysfunction during childhood? Pediatr Int 2008;50:150-3
  17. Kurekci AE, Atay AA, Sarici SU, Ozcan O. Complete platelet recovery after treatment of